Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 7
2005 12
2006 11
2007 16
2008 9
2009 13
2010 10
2011 10
2012 10
2013 8
2014 11
2015 13
2016 12
2017 17
2018 10
2019 7
2020 8
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

154 results
Results by year
Filters applied: . Clear all
Page 1
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities.
Narayan RS, Molenaar P, Teng J, Cornelissen FMG, Roelofs I, Menezes R, Dik R, Lagerweij T, Broersma Y, Petersen N, Marin Soto JA, Brands E, van Kuiken P, Lecca MC, Lenos KJ, In 't Veld SGJG, van Wieringen W, Lang FF, Sulman E, Verhaak R, Baumert BG, Stalpers LJA, Vermeulen L, Watts C, Bailey D, Slotman BJ, Versteeg R, Noske D, Sminia P, Tannous BA, Wurdinger T, Koster J, Westerman BA. Narayan RS, et al. Among authors: stalpers lja. Nat Commun. 2020 Jun 10;11(1):2935. doi: 10.1038/s41467-020-16735-2. Nat Commun. 2020. PMID: 32523045 Free PMC article.
Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer.
Oei AL, Korangath P, Mulka K, Helenius M, Coulter JB, Stewart J, Velarde E, Crezee J, Simons B, Stalpers LJA, Kok HP, Gabrielson K, Franken NAP, Ivkov R. Oei AL, et al. Among authors: stalpers lja. Int J Hyperthermia. 2019 Nov;36(sup1):47-63. doi: 10.1080/02656736.2019.1685686. Int J Hyperthermia. 2019. PMID: 31795835 Free PMC article.
Advanced patient-specific hyperthermia treatment planning.
Gavazzi S, van Lier ALHMW, Zachiu C, Jansen E, Lagendijk JJW, Stalpers LJA, Crezee H, Kok HP. Gavazzi S, et al. Among authors: stalpers lja. Int J Hyperthermia. 2020;37(1):992-1007. doi: 10.1080/02656736.2020.1806361. Int J Hyperthermia. 2020. PMID: 32806979
Sensitizing thermochemotherapy with a PARP1-inhibitor.
Oei AL, Vriend LE, van Leeuwen CM, Rodermond HM, Ten Cate R, Westermann AM, Stalpers LJ, Crezee J, Kanaar R, Kok HP, Krawczyk PM, Franken NA. Oei AL, et al. Oncotarget. 2017 Mar 7;8(10):16303-16312. doi: 10.18632/oncotarget.11422. Oncotarget. 2017. PMID: 27557507 Free PMC article.
154 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page